Skip to main content

Thomas Roberts Kinney, MD

Wilburt C. Davison Professor of Pediatrics, in the School of Medicine
Professor of Pediatrics
Associate Chair, Department of Pediatrics
Campus mail: 0901 Childrens Hlth Ctr, Durham, NC 27710
Phone: (919) 681-4443
Email address: kinne001@mc.duke.edu

For the past 15 years, Thomas R. Kinney, MD has focused his clinical research efforts on sickle cell. He has been a leader in the NIH funded multi-institutional collaborative study that began in 1978 to define the natural history of sickle cell disease. He also has played a pivotal role in the implementation and monitoring of the North Carolina Neonatal Hemoglobinopathy Screening Program. In 1993, he served as Co-Chairman of a Federal Panel convened by the Agency for Health Care Policy and Research to develop guidelines for sickle cell screening programs.

Dr. Kinney currently serves as the Associate Chairman Emeritus of the Department of Pediatrics.

Education and Training

  • M.D., Duke University, 1970

Publications

Dean, D, Neumayr, L, Kelly, DM, Ballas, SK, Kleman, K, Robertson, S, Iyer, RV, Ware, RE, Koshy, M, Rackoff, WR, Pegelow, CH, Waldron, P, Benjamin, L, Vichinsky, E, and Acute Chest Syndrome Study Group, . "Chlamydia pneumoniae and acute chest syndrome in patients with sickle cell disease." Journal of Pediatric Hematology/Oncology 25, no. 1 (January 2003): 46-55.

Full Text

Wang, WC, Helms, RW, Lynn, HS, Redding-Lallinger, R, Gee, BE, Ohene-Frempong, K, Smith-Whitley, K, Waclawiw, MA, Vichinsky, EP, Styles, LA, Ware, RE, and Kinney, TR. "Effect of hydroxyurea on growth in children with sickle cell anemia: results of the HUG-KIDS Study." The Journal of Pediatrics 140, no. 2 (February 2002): 225-229.

Full Text

Pegelow, CH, Macklin, EA, Moser, FG, Wang, WC, Bello, JA, Miller, ST, Vichinsky, EP, DeBaun, MR, Guarini, L, Zimmerman, RA, Younkin, DP, Gallagher, DM, and Kinney, TR. "Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease." Blood 99, no. 8 (2002): 3014-3018.

Full Text

Ware, RE, Eggleston, B, Redding-Lallinger, R, Wang, WC, Smith-Whitley, K, Daeschner, C, Gee, B, Styles, LA, Helms, RW, Kinney, TR, and Ohene-Frempong, K. "Predictors of fetal hemoglobin response in children with sickle cell anemia receiving hydroxyurea therapy." Blood 99, no. 1 (January 2002): 10-14.

Full Text

Miller, ST, Macklin, EA, Pegelow, CH, Kinney, TR, Sleeper, LA, Bello, JA, DeWitt, LD, Gallagher, DM, Guarini, L, Moser, FG, Ohene-Frempong, K, Sanchez, N, Vichinsky, EP, Wang, WC, Wethers, DL, Younkin, DP, Zimmerman, RA, DeBaun, MR, and Cooperative Study of Sickle Cell Disease, . "Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the Cooperative Study of Sickle Cell Disease." The Journal of Pediatrics 139, no. 3 (September 2001): 385-390.

Full Text

O'branski, EE, Ware, RE, Prose, NS, and Kinney, TR. "Skin and nail changes in children with sickle cell anemia receiving hydroxyurea therapy." J Am Acad Dermatol 44, no. 5 (May 2001): 859-861.

Full Text

Wigfall, DR, Ware, RE, Burchinal, MR, Kinney, TR, and Foreman, JW. "Prevalence and clinical correlates of glomerulopathy in children with sickle cell disease." J Pediatr 136, no. 6 (June 2000): 749-753.

Scholars@Duke

Miller, ST, Sleeper, LA, Pegelow, CH, Enos, LE, Wang, WC, Weiner, SJ, Wethers, DL, Smith, J, and Kinney, TR. "Prediction of adverse outcomes in children with sickle cell disease." The New England Journal of Medicine 342, no. 2 (January 2000): 83-89.

Full Text

Thompson, RJ, Gustafson, KE, Gil, KM, Kinney, TR, and Spock, A. "Change in the Psychological Adjustment of Children with Cystic Fibrosis or Sickle Cell Disease and Their Mothers." Journal of Clinical Psychology in Medical Settings 6, no. 4 (December 1, 1999): 373-392.

Scholars@Duke

Kinney, TR, Helms, RW, O'Branski, EE, Ohene-Frempong, K, Wang, W, Daeschner, C, Vichinsky, E, Redding-Lallinger, R, Gee, B, Platt, OS, and Ware, RE. "Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group." Blood 94, no. 5 (September 1, 1999): 1550-1554.

Scholars@Duke

Pages